Fermenta Biotech Limited's officials will engage with investors in a one-to-one physical meeting in Mumbai. The company will discuss information already available in its public press releases and investor presentations. It has been confirmed that no new unpublished price sensitive information will be shared during this interaction, ensuring transparency and equal access to information for all shareholders.